Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lupus Atherosclerosis Prevention Study
NCT00120887Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in systemic lupus erythematosus (SLE) comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Progression of atherosclerosis on helical CT or carotid duplex at 2 years, Coronary calcification on multislice helical CT at 2 years and 2 more. Started Apr 2002; status: completed.
02
Drugs
atorvastatin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00120887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120887.